Claudio Doglioni

27PUBLICATIONS
229CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Nov 04, 2026
IFNAR1 stabilization sustains CD8+ T cell persistence in IFN-high colorectal cancer liver metastases.

|Sep 16, 2026
Immunohistochemical stratification of bladder small cell carcinoma reveals two major phenotypes with distinct therapeutic biomarker profiles.

|Jul 13, 2026
The H63D Polymorphism in the HFE Gene Promotes Aggressive Disease Phenotypes in Pancreatic Ductal Adenocarcinoma.

|Jun 10, 2026
The promyelocytic leukemia PML protein coordinates immune evasion in triple-negative breast cancer via independent and converging mechanisms.

|Jan 08, 2026
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength.

Martina Spiga, Alessia Potenza, Zulma Magnani

|May 28, 2025
Systemic delivery of cadherin 17-specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases.

Pageof 5

Frequent Collaborators

5 joint publications

Chiara Bonini

4 joint publications

Massimo Falconi

3 joint publications

Chiara Balestrieri

3 joint publications

Lorenzo Dagna